Trial intelligence / Profile preview

Levothyroxine in Pregnant SLE Patients With Autoimmune Thyroid Disease

NCT01276782Phase 4Withdrawn

Sponsor
Johns Hopkins University
Start
Jan 2011
Primary completion
Jun 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of levothyroxine sodium in autoimmune thyroid disease (AITD), sponsored by Johns Hopkins University. Planned start Jan 2011; status: withdrawn.

02

Drugs

levothyroxine sodium
03

Conditions

autoimmune thyroid disease (AITD)

Beyond the preview

Go deeper on NCT01276782.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01276782.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call